{"schema_version":"1","generated_at":"2026-11-21T11:25:52.951Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lamont-weide","json_url":"https://www.findmykol.com/kol/lamont-weide/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lamont-weide","name":"Lamont Weide","credential":"MD, PhD, FACE","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Endocrinology/Metabolic","therapeutic_areas":["Endocrinology/Metabolic"],"institution":"University of Missouri–Kansas City","institution_url":"https://www.findmykol.com/institution/university-of-missouri-kansas-city","city":"Kansas City","state":"MO","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Lamont Weide is an Endocrinology/Metabolic physician affiliated with University of Missouri–Kansas City. OpenAlex indexes 48 publications with 1,468 citations (h-index 15).","overview":null,"focus":{"indications":[],"research_topics":["Endocrinology/Metabolic"]},"scholarship":{"works_count":48,"cited_by_count":1468,"h_index":15,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":8,"shown":3,"withheld":5,"rows":[{"payer":"PFIZER INC.","program_year":2025,"amount_usd":14.97,"payment_count":1},{"payer":"Lilly USA, LLC","program_year":2023,"amount_usd":69.58,"payment_count":4},{"payer":"ANI Pharmaceuticals, Inc.","program_year":2023,"amount_usd":32.3,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":7,"areas_shown":3,"areas":[{"area":"Cardiovascular","share_pct":41.9,"classes_total":14,"classes":[{"class":"Statin","setting":"prescribed","share_pct":14.8,"drugs":[{"name":"Atorvastatin Calcium","share_pct":73.7},{"name":"Rosuvastatin Calcium","share_pct":17.3},{"name":"Pravastatin Sodium","share_pct":7.1},{"name":"Lovastatin","share_pct":1.9}],"max_beneficiaries":null},{"class":"Calcium channel blocker","setting":"prescribed","share_pct":5.6,"drugs":[{"name":"Amlodipine Besylate","share_pct":94.2},{"name":"Nifedipine Er","share_pct":5.8}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":39.9,"classes_total":10,"classes":[{"class":"GLP-1 receptor agonist","setting":"prescribed","share_pct":11.1,"drugs":[{"name":"Trulicity","share_pct":47.1},{"name":"Ozempic","share_pct":40.2},{"name":"Victoza 3-Pak","share_pct":5.9},{"name":"Rybelsus","share_pct":3.8},{"name":"Victoza 2-Pak","share_pct":3.1}],"max_beneficiaries":null},{"class":"Insulin Analog","setting":"prescribed","share_pct":11.1,"drugs":[{"name":"Lantus Solostar","share_pct":36},{"name":"Novolog Flexpen","share_pct":21.1},{"name":"Humalog Kwikpen U-100","share_pct":10.9},{"name":"Novolog","share_pct":7.3},{"name":"Insulin Lispro Kwikpen U-100","share_pct":6.9},{"name":"Tresiba Flextouch U-100","share_pct":6.3},{"name":"Basaglar Kwikpen U-100","share_pct":5.9},{"name":"Tresiba Flextouch U-200","share_pct":3.1},{"name":"Humalog","share_pct":2.5}],"max_beneficiaries":null}]},{"area":"Hormonal (systemic)","share_pct":14.7,"classes_total":3,"classes":[{"class":"l-Thyroxine","setting":"prescribed","share_pct":12.9,"drugs":[{"name":"Levothyroxine Sodium","share_pct":87.2},{"name":"Synthroid","share_pct":12.8}],"max_beneficiaries":112},{"class":"Thyroid Hormone Synthesis Inhibitor","setting":"prescribed","share_pct":1.5,"drugs":[{"name":"Methimazole","share_pct":100}],"max_beneficiaries":14}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":48,"shown":5,"withheld":43,"matched_by":"OpenAlex author record","recent":[{"title":"Synchronous muscle and bone metastases in thyroid cancer","year":2025,"journal":"Journal of Clinical and Translational Endocrinology Case Reports","source_url":"https://doi.org/10.1016/j.jecr.2025.100204","status":"verified"},{"title":"SAT-584 Skeletal Muscle and Bone Metastases in Papillary Thyroid Microcarcinoma","year":2024,"journal":"Journal of the Endocrine Society","source_url":"https://doi.org/10.1210/jendso/bvae163.2447","status":"verified"},{"title":"Thyrotoxic Periodic Paralysis as an Ongoing Diagnostic Challenge: A Case Report and Literature Review.","year":2023,"journal":"PubMed","source_url":"https://doi.org/10.7759/cureus.46272","status":"verified"},{"title":"A Case-Based Comparison of the American Thyroid Association and Thyroid Imaging Reporting & Data System Guidelines.","year":2022,"journal":"PubMed","status":"verified"},{"title":"Clozapine Induced Insulin Dependence","year":2021,"journal":"Journal of the Endocrine Society","source_url":"https://doi.org/10.1210/jendso/bvab048.757","status":"verified"}],"source":"works"},"similar":[{"name":"John Spertus","slug":"john-spertus","institution":"University of Missouri–Kansas City","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/john-spertus","json_url":"https://www.findmykol.com/kol/john-spertus/profile.json"},{"name":"Barry Rutherford","slug":"barry-rutherford","institution":"University of Missouri–Kansas City","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/barry-rutherford","json_url":"https://www.findmykol.com/kol/barry-rutherford/profile.json"},{"name":"Gary Lofland","slug":"gary-lofland","institution":"University of Missouri–Kansas City","specialty":"Pediatric Surgery","url":"https://www.findmykol.com/kol/gary-lofland","json_url":"https://www.findmykol.com/kol/gary-lofland/profile.json"},{"name":"Jessica Hellings","slug":"jessica-hellings","institution":"University of Missouri–Kansas City","specialty":"Child & Adolescent Psychiatry","url":"https://www.findmykol.com/kol/jessica-hellings","json_url":"https://www.findmykol.com/kol/jessica-hellings/profile.json"},{"name":"Yousef Saleh Khader","slug":"yousef-khader","institution":"Jordan University of Science and Technology","url":"https://www.findmykol.com/kol/yousef-khader","json_url":"https://www.findmykol.com/kol/yousef-khader/profile.json"},{"name":"Jens Juul Holst","slug":"jens-holst","institution":"University of Copenhagen","url":"https://www.findmykol.com/kol/jens-holst","json_url":"https://www.findmykol.com/kol/jens-holst/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Christos Mantzoros","slug":"christos-mantzoros","institution":"Harvard Medical School","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/christos-mantzoros","json_url":"https://www.findmykol.com/kol/christos-mantzoros/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":5,"publications":43}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}